Eric Lefkofsky is an entrepreneur based out of Chicago, IL. For the past several years, Lefkofsky has made an impact in the technological field thanks to his ability to expertly work with data collection and analytics. Now, Lefkofsky is taking his natural skills and talent and putting it toward developing the company that he co-founded just a few years ago, Tempus. Tempus is a business that is focused primarily on the collection and subsequent analysis of clinical and molecular data. The goal of Tempus is to provide physicians with the genomic and clinical data that they need in order to find appropriate treatment routines for patients fighting cancer. Now, Lefkofsky and Tempus are unveiling a brand new mobile application to make that task even easier: Tempus Labs.
Tempus Labs is available on both the iOS App Store and the Google Play store. The application had been going through stress testing for several months now by being put into the hands of capable physicians throughout the nation. Now, with a full release on the docket, Tempus Labs will be usable by physicians who are in possession of the Tempus CLIA/CAP Validated Assays, of which there are three: xT (595 genes), xO (1714 genes); and xE (whole exome). The application was developed by Lefkofsky in conjunction with the COO of Tempus, Ryan Fukushima. The application will give physicians the ability to access the data that they need no matter where they are at, so long as their mobile app is installed and accessible. The application will go a long way toward giving physicians and their patients all of the necessary tools to set up a regiment that is effective for the personalized treatment of cancer.
The announcement of Tempus Labs comes on the heels of Tempus raising an incredible $110 million in Series E funding. Tempus has been growing exponentially over the last year and the odds are good that they’ll continue this rate of pace into the foreseeable future. Tempus will be another addition to Lefkofsky’s legacy of Chicago-made startups that have fundamentally changed the way that we live our lives.
About Eric Lefkofsky: www.britannica.com/biography/Eric-Lefkofsky